• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预防志贺氏菌病的合成碳水化合物偶联疫苗候选物:改进的生物偶联及明矾对免疫原性的影响

A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity.

作者信息

van der Put Robert M F, Kim Tae Hee, Guerreiro Catherine, Thouron Françoise, Hoogerhout Peter, Sansonetti Philippe J, Westdijk Janny, Stork Michiel, Phalipon Armelle, Mulard Laurence A

机构信息

Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands.

Unité de Chimie des Biomolécules, Institut Pasteur , 28 rue du Dr Roux, 75 724 Paris Cedex 15, France.

出版信息

Bioconjug Chem. 2016 Apr 20;27(4):883-92. doi: 10.1021/acs.bioconjchem.5b00617. Epub 2016 Mar 21.

DOI:10.1021/acs.bioconjchem.5b00617
PMID:26918643
Abstract

Conjugation chemistry is among the most important parameters governing the efficacy of glycoconjugate vaccines. High robustness is required to ensure high yields and batch to batch reproducibility. Herein, we have established a robust bioconjugation protocol based on the thiol-maleimide addition. Major variables were determined and acceptable margins were investigated for a synthetic pentadecasaccharide-tetanus toxoid conjugate, which is a promising vaccine candidate against Shigella flexneri serotype 2a infection. The optimized process is applicable to any thiol-equipped hapten and provides an efficient control of the hapten:carrier ratio. Moreover, comparison of four S. flexneri 2a glycoconjugates only differing by their pentadecasaccharide:tetanus toxoid ratio confirmed preliminary findings indicating that hapten loading is critical for immunogenicity with an optimal ratio here in the range of 17 ± 5. In addition, the powerful influence of alum on the immunogenicity of a Shigella synthetic carbohydrate-based conjugate vaccine candidate is demonstrated for the first time, with a strong anti-S. flexneri 2a antibody response sustained for more than one year.

摘要

共轭化学是影响糖共轭疫苗效力的最重要参数之一。需要高稳健性以确保高产量和批次间的可重复性。在此,我们基于硫醇-马来酰亚胺加成反应建立了一种稳健的生物共轭方案。对于一种有望用于预防福氏志贺菌2a型感染的合成十五糖-破伤风类毒素共轭物,我们确定了主要变量并研究了可接受范围。优化后的工艺适用于任何带有硫醇的半抗原,并能有效控制半抗原与载体的比例。此外,对四种仅十五糖与破伤风类毒素比例不同的福氏志贺菌2a型糖共轭物进行比较,证实了初步研究结果,即半抗原负载量对免疫原性至关重要,此处最佳比例在17±5范围内。此外,首次证明了明矾对一种基于志贺菌合成碳水化合物的共轭疫苗候选物免疫原性的强大影响,产生了持续一年多的强烈抗福氏志贺菌2a型抗体反应。

相似文献

1
A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity.一种用于预防志贺氏菌病的合成碳水化合物偶联疫苗候选物:改进的生物偶联及明矾对免疫原性的影响
Bioconjug Chem. 2016 Apr 20;27(4):883-92. doi: 10.1021/acs.bioconjchem.5b00617. Epub 2016 Mar 21.
2
A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.一种针对福氏志贺菌2a感染的合成碳水化合物-蛋白质结合疫苗候选物。
J Immunol. 2009 Feb 15;182(4):2241-7. doi: 10.4049/jimmunol.0803141.
3
Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine.福氏志贺菌2a血清型O抗原功能性寡糖模拟物的表征:对化学定义的糖缀合物疫苗开发的启示
J Immunol. 2006 Feb 1;176(3):1686-94. doi: 10.4049/jimmunol.176.3.1686.
4
In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation.重组大肠杆菌体内生产针对福氏志贺菌2a的新型糖缀合物疫苗:体内糖基化刺激因子的鉴定
Microb Cell Fact. 2015 Jan 23;14:12. doi: 10.1186/s12934-015-0195-7.
5
Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.宋内志贺菌-CRM9与福氏2a型志贺菌-rEPA琥珀酸共轭疫苗在1至4岁儿童中的安全性和免疫原性。
Pediatr Infect Dis J. 2003 Aug;22(8):701-6. doi: 10.1097/01.inf.0000078156.03697.a5.
6
Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.基于脂质体的双表位构建体的合理设计与免疫原性:应用于模拟福氏志贺菌2a O抗原的合成寡糖
Vaccine. 2009 Aug 27;27(39):5419-26. doi: 10.1016/j.vaccine.2009.06.031. Epub 2009 Jun 24.
7
Glycoconjugation of Shigella flexneri type 2a O-polysaccharide with CRM as a potential vaccine candidate for shigellosis.志贺氏菌 2a 型 O-多糖与 CRM 的糖缀合作为志贺菌病的潜在疫苗候选物。
Biologicals. 2021 Jul;72:1-9. doi: 10.1016/j.biologicals.2021.07.001. Epub 2021 Jul 8.
8
The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against .首个用于人体的基于合成聚糖的抗……共轭疫苗候选物
ACS Cent Sci. 2022 Apr 27;8(4):449-460. doi: 10.1021/acscentsci.1c01479. Epub 2022 Mar 17.
9
Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease.合成糖缀合物作为抗福氏志贺菌2a型疾病潜在疫苗的制备
Org Biomol Chem. 2004 May 21;2(10):1518-27. doi: 10.1039/b400986J. Epub 2004 Apr 26.
10
Further characterization of -specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a 2a synthetic glycan-based vaccine candidate.进一步鉴定 SF2a-TT15(一种 2a 合成糖基疫苗候选物)诱导的健康志愿者受体中产生的 -特异性(记忆)B 细胞。
Front Immunol. 2023 Oct 31;14:1291664. doi: 10.3389/fimmu.2023.1291664. eCollection 2023.

引用本文的文献

1
Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.针对福氏志贺菌 6 型的志贺氏菌结合疫苗的开发,该疫苗具有免疫原性,能提供针对强毒力挑战的保护。
Vaccine. 2024 Oct 24;42(24):126263. doi: 10.1016/j.vaccine.2024.126263. Epub 2024 Aug 31.
2
Vaccines: The Continuing Unmet Challenge.疫苗:持续未被满足的挑战。
Int J Mol Sci. 2024 Apr 13;25(8):4329. doi: 10.3390/ijms25084329.
3
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry.
利用新型平台偶联技术——丁烯二酸化学法,研制针对福氏 2a 亚型和福氏 3a 亚型志贺菌的志贺菌结合疫苗。
Vaccine. 2023 Jul 31;41(34):4967-4977. doi: 10.1016/j.vaccine.2023.06.052. Epub 2023 Jul 1.
4
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines.探索影响传统和创新糖缀合物疫苗免疫反应的变量。
Front Mol Biosci. 2023 May 16;10:1201693. doi: 10.3389/fmolb.2023.1201693. eCollection 2023.
5
A Novel O-Polysaccharide-IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Serotypes.一种新型 O-多糖-IpaB 缀合疫苗可诱导强烈的抗体应答,并针对多种血清型提供保护。
mSphere. 2023 Jun 22;8(3):e0001923. doi: 10.1128/msphere.00019-23. Epub 2023 Apr 5.
6
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults.一种基于福氏志贺菌2a合成聚糖的疫苗可在成人中诱导持久的免疫反应。
NPJ Vaccines. 2023 Mar 10;8(1):35. doi: 10.1038/s41541-023-00624-y.
7
Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines.基于细菌多糖重复单元的抗菌结合疫苗概念的发展。
ACS Infect Dis. 2023 Feb 10;9(2):178-212. doi: 10.1021/acsinfecdis.2c00559. Epub 2023 Jan 27.
8
Complement-mediated serum bactericidal activity of antibodies elicited by the GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.志贺菌病流行国家成人中 GMMA 疫苗诱导的抗体的补体介导的血清杀菌活性:2a 期随机研究的探索性分析。
Front Immunol. 2022 Sep 9;13:971866. doi: 10.3389/fimmu.2022.971866. eCollection 2022.
9
The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against .首个用于人体的基于合成聚糖的抗……共轭疫苗候选物
ACS Cent Sci. 2022 Apr 27;8(4):449-460. doi: 10.1021/acscentsci.1c01479. Epub 2022 Mar 17.
10
Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against : State-of-the-Art for a Monovalent Prototype and Challenges.迈向一种基于多价合成寡糖的结合疫苗:单价原型的现状与挑战
Vaccines (Basel). 2022 Mar 7;10(3):403. doi: 10.3390/vaccines10030403.